New York—May 6, 2013
Clinical pathways and quality initiatives leading to world class outcomes are the foundation of a far-reaching agreement between New York-based Hospital for Special Surgery, the recognized leader in orthopedics, rheumatology and related specialties, and Amil Par, the largest managed healthcare organization in Brazil, on behalf of Hospitalys Ortopedia, its newly opened orthopedic center in Rio de Janeiro.
The collaboration reinforces Amil Par’s reputation for leadership with the February opening of Hospitalys, which specializes in spine disorders, joint replacement and sports medicine, orthopedic areas for which Hospital for Special Surgery is world renowned.
Hospitalys and the Brazilian medical community are preparing now for two major sports events. Rio is the host city of the 2016 Summer Olympics. Brazil is also anticipating the medical challenges of the international sports community coming for the 2014 FIFA World Cup.
“Our joint endeavors will be targeted on sharing the depth of our experience in delivering world class quality care and outcomes,” said Hospital for Special Surgery President and CEO Louis A. Shapiro. “We are pleased to be part of a continuing collaboration that reflects both of our institutions’ dedication to academic excellence and innovative research in orthopedics.”
The agreement lays out the next steps planned for the multi-year collaboration focusing on quality management and outcomes. The two organizations will establish a Quality Advisory Council to provide oversight to set priorities and monitor progress. In addition to identifying research priorities, initiatives will offer continued assessment, education and training through fellowships and continuing education programs in both countries as well as digital education through HSS e-University.
“We are proud and excited to continue this strong relationship,” said Casio Zandona, CEO/RJ for Amil Par. “Hospital for Special Surgery is the ideal partner for this initiative with their expertise and outstanding reputation in orthopedics, especially in sports medicine. The planned educational outreach outlined in the agreement will offer major benefits to physicians and health professionals throughout Brazil and beyond.”
“For the initial phase, a key focus will involve development of staff and identification of eight quality initiatives,” explained Laura Robbins, DSW, senior vice president of Education and Academic Affairs, Hospital for Special Surgery, who is charged with administering the collaborative relationship. These initiatives include quality management, patient flow, perioperative services, nursing, rehabilitation, length of stay, discharge protocols and basic research.
The two organizations began to collaborate in early 2012 with programming that included assessments, observational visits and an international orthopedics symposium held in Brazil in November that brought Special Surgery experts in sports medicine, joint replacement, spine surgery and rehabilitation to speak before a region-wide invited medical audience.
U.S. health insurer UnitedHealth Group Inc announced in October 2012 that it will buy control of Amil Par (Amil Participacoes SA) for $4.9 billion, making a bold move into a fast-growing market. In making the announcement, UnitedHealth executives noted that the Brazilian healthcare market had been bolstered by a growing middle class and was turning to managed care to meet demand. They went on to note that it is expected to grow twice as fast as the U.S. market.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.